Senti Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $5,856 | $0 |
Gross Profit | -1,476 | 2,928 | ||
EBITDA | -13,257 | -14,929 | -5,002 | -13,438 |
EBIT | -14,733 | -16,397 | -610 | -14,902 |
Net Income | -14,733 | -14,112 | -610 | -28,866 |
Net Change In Cash | 0 | 0 | 5,856 | 0 |
Free Cash Flow | -13,269 | -14,050 | -13,515 | -7,866 |
Cash | 21,576 | 33,802 | 48,277 | 10,479 |
Basic Shares | 26,081 | 4,595 | 4,595 | 4,577 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $2,561 | $4,286 | $2,291 |
Gross Profit | -2,683 | 4,286 | -719 | |
EBITDA | -46,939 | -61,336 | -66,709 | -39,677 |
EBIT | -52,790 | -66,765 | -70,629 | -42,687 |
Net Income | -52,790 | -92,919 | -45,791 | -55,319 |
Net Change In Cash | 0 | 2,561 | 4,286 | 2,291 |
Cost of Revenue | 1,696 | |||
Free Cash Flow | -41,423 | -64,433 | -76,270 | -40,178 |
Cash | 48,277 | 35,926 | 57,621 | 56,034 |
Basic Shares | 4,596 | 4,437 | 4,394 | 4,365 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.56 |
2025-03-31 | -$1.41 |
2024-12-31 | -$0.67 |
2024-09-30 | -$6.30 |
